Literature DB >> 25200171

The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer.

Hirofumi Mukai1, Tomohiko Aihara, Yutaka Yamamoto, Masato Takahashi, Tatsuya Toyama, Yasuaki Sagara, Hiroshi Yamaguchi, Hiromitsu Akabane, Junji Tsurutani, Fumikata Hara, Tomomi Fujisawa, Naohito Yamamoto, Shozo Ohsumi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25200171     DOI： 10.1007/s12282-014-0563-x

Source DB:  PubMed          Journal:  Breast Cancer        ISSN： 1340-6868            Impact factor:   4.239


× No keyword cloud information.
  7 in total

1.  Clinicopathological relevance of kinesin family member 18A expression in invasive breast cancer.

Authors:  Mai Kasahara; Makoto Nagahara; Tsuyoshi Nakagawa; Toshiaki Ishikawa; Takanobu Sato; Hiroyuki Uetake; Kenichi Sugihara
Journal:  Oncol Lett       Date:  2016-07-07       Impact factor: 2.967

2.  Adjuvant ovarian suppression for premenopausal hormone receptor-positive breast cancer: A network meta-analysis.

Authors:  Mengjie Jiang; Wuzhen Chen; Yujie Hu; Chao Chen; Huafeng Li
Journal:  Medicine (Baltimore)       Date:  2021-08-20       Impact factor: 1.817

3.  Attitudes and practice patterns for maintaining relative dose intensity of chemotherapy in outpatient clinics: results of a Japanese web-based survey.

Authors:  Hitomi Sakai; Noriyuki Katsumata; Genmu Kadokura
Journal:  BMC Cancer       Date:  2015-10-05       Impact factor: 4.430

4.  APOBEC3B gene expression as a novel predictive factor for pathological complete response to neoadjuvant chemotherapy in breast cancer.

Authors:  Yoshitaka Fujiki; Yutaka Yamamoto; Aiko Sueta; Mutsuko Yamamoto-Ibusuki; Lisa Goto-Yamaguchi; Mai Tomiguchi; Takashi Takeshita; Hirotaka Iwase
Journal:  Oncotarget       Date:  2018-07-17

5.  Impact of prognostic nutritional index on long-term outcomes in patients with breast cancer.

Authors:  Tomomi Mohri; Yasuhiko Mohri; Tsunehiko Shigemori; Kenji Takeuchi; Yoshiyuki Itoh; Toshio Kato
Journal:  World J Surg Oncol       Date:  2016-06-27       Impact factor: 2.754

6.  Pathological tumor regression grade of metastatic tumors in lymph node predicts prognosis in esophageal cancer patients.

Authors:  Tomohiro Kadota; Ken Hatogai; Tomonori Yano; Takeo Fujita; Takashi Kojima; Hiroyuki Daiko; Satoshi Fujii
Journal:  Cancer Sci       Date:  2018-05-03       Impact factor: 6.716

Review 7.  Shared decision making in breast cancer treatment guidelines: Development of a quality assessment tool and a systematic review.

Authors:  Marta Maes-Carballo; Isabel Muñoz-Núñez; Manuel Martín-Díaz; Luciano Mignini; Aurora Bueno-Cavanillas; Khalid Saeed Khan
Journal:  Health Expect       Date:  2020-08-03       Impact factor: 3.377
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.